Crop Biotech Update

A weekly summary of world developments in agri-biotech for developing countries, produced by the Global Knowledge Center on Crop Biotechnology, International Service for the Acquisition of Agri-biotech Applications SEAsiaCenter (ISAAA), and AgBiotechNet

September 3, 2003

In This Issue:

GAO Report: Biotech Foods ‘As Safe As Conventional Foods’
Economics of Ag-biotech Private and Public Research
EU Directives on GM Seeds
Chinese Consumers: Low Knowledge of GM Foods
Factors Affecting China’s Import Regulations on GMF
Non-GM and GM Rape – Bees Don’t Care
Biotech Partnership Between Pakistan and China
Announcement:
Politics and Communication in GM Debate
Future of Food and Biotech Conference
Fischler on GMO Co-Existence
 

 

GAO REPORT: BIOTECH FOODS 'AS SAFE AS CONVENTIONAL FOODS'

The General Accounting Office of the U.S. government has released a report concluding that foods produced using biotechnology are as safe as conventional foods. It stated that there is no scientific evidence that they would cause long-term health risks to consumers.

The report entitled “Genetically Modified Foods: Experts View Regimen of Safety Tests as Adequate, but FDA’s Evaluation Process Could Be Enhanced” notes that “Foods from GM plants pose three types of risk to human health: they can potentially contain allergens, toxins, or antinutrients. These risks are not unique to GM foods. People have consumed foods containing allergens, toxins and antinutrients throughout history.”

In addition, suggestions were made to improve the process being followed by the US Food and Drug Administration to evaluate new biotech foods. The FDA, according to the report, should enhance its oversight role in two ways. One is to randomly verify the raw data companies provide about new products since the agency currently reviews summaries of that data. The second is to improve its system of informing the public about its evaluation process and the scientific rationale behind its decisions.

The full report can be viewed at http://www.gao.gov/new.items/d02566.pdf. A news item on the report is available at http://www.whybiotech.com/index.asp?id=2098


EU DIRECTIVES ON GM SEEDS

A separate legislation has been formulated by the European Union (EU) specifically for genetically modified (GM) seeds. All GM seed varieties have to be approved and authorized for cultivation in the EU under Directive 2001/18. Authorization is only granted after scientific assessments have concluded that the GM seeds do not pose any risks to the environment or to human health.

The EU Directives on the marketing of agricultural and vegetable seeds aim to improve the quality of seeds (e.g. identity and purity of the variety) that are currently marketed in the EU. Requirements were specifically made regarding sealing, labeling and documentation.

Further, a minimum threshold for the presence of authorized GM varieties was specified for seed lots of non-genetically modified (non-GM) varieties. To date, only GM-maize, GM-swede rape, GM-soya bean and GM-chicory are currently authorized in the EU. Requests for authorization for GM-potatoes, GM-beet and GM-cotton have already been made.

The Commission proposes a threshold for GM-presence in conventional seeds according to the species, and the reproductive systems of the plants. Thresholds specified for GM crops are as follows: 0.3% for swede rape; 0.5% for beet, maize, potato, cotton, chicory and tomato; and 0.7% for soya bean.

For Questions and Answers about GMOs in seeds, please visit http://europa.eu.int/rapid/start/cgi/guesten.ksh?p_action.gettxt=gt&doc
=MEMO/03/186|0|RAPID&lg=EN&display=


FACTORS AFFECTING CHINA’S IMPORT REGULATIONS ON GMF

Several factors are shaping China’s regulations on imports of transgenic food products, particularly soybeans. These include food safety considerations, protection of China’s domestic producers, consumers, and crusher’s demand for soybeans, World Trade Organization commitments, and political factors. This is the assessment of Mary Marchant of the University of Kentucky and colleagues in an article on “Issues on Adoption, Import Regulations, and Policies for Biotech Commodities in China with a Focus on Soybeans”.

Health was identified as a major determinant affecting decisions on adoption of production technologies that use biotechnology, and regulations in imports of transgenic food products. Implementation of import regulations is also projected as a tool to protect China’s domestic producers.

Despite these factors, however, China’s strong and growing domestic demand for imported soybean will continue to affect the implementation of import regulations. Future decisions will also be affected by international debates on biotech product issues.

The full article in available online at http://www.agbioforum.org/v5n4/v5n4a05-marchant.htm


BIOTECH PARTNERSHIP BETWEEN PAKISTAN AND CHINA

Pakistan has recently signed an agreement with China to increase its global biotechnology presence by agreeing to exchange biotechnology experts and to collaborate in plant and rice genomics research.

According to Professor Atta-ur-Rahman, Federal Minister for Science and Technology and leader of the negotiations with China, Pakistan has the potential to become a player in the global biotechnology market in the next three to five years. Rahman added that Pakistan's agriculture-based economy and strong research and development infrastructure would also help attract international investment.

Early in the year, Pakistan released a national biotechnology action plan that aims to prioritize vaccine production, biodiagnostics, and improved crop yields. And for over the past three years, Pakistan has invested US$16.5 million in biotechnology promotion. At present, about 50 new biotechnology projects ranging from the design of new textbooks to research into blight-resistant rice varieties are underway.

Further, Pakistani officials recently devised new biosafety guidelines that will serve as a framework for future national biotechnology initiatives. These guidelines are being reviewed by Pakistan's Ministry of Environment.

The new release can be found at Nature Biotechnology.


POLITICS AND COMMUNICATION IN GM DEBATE

The recent public debate in Europe and the trade row between the United States and the European Union have shown that there is a need for more impartial communications, less propaganda and an effective regulatory regime that is based an a careful case-by-case consideration of genetically modified technology. These requirements must be met so that developing nations who have the most to gain from the technology can start to reap its benefits. This is the view shared by Charles Arntzen of Arizona State University and his colleagues in an article entitled “GM Crops: Science, Politics, and Communication” published in Nature Reviews. They raise several key points:

  • Positioning genetically modified crops as “good or bad” is a failure to recognize that each product of plant biotechnology is a discrete technology package that must be discussed on its individual merit.
  • Improving public knowledge means working with media and public bodies over a sustained period, using evidence-based material, not rhetorical hype.
  • The actual experience of a disastrous food crisis has had more impact on public attitudes than the different modes of media coverage. Restoring structure and credibility in science and government will require open dialogue, transparency, and time. However, consumers must see some perceived value for attitudes to change.
  • GM crops are here to stay and the timing of their adoption will be determined by the economic and societal impact of each product.

The article ends with the conclusion that “as the technology matures and disperses, and as other nations begin to develop their own varieties that deliver value to their farmers and citizens, GM crops will lose their globalization stigma and become more widely accepted around the world.”

Read the whole article in Nature Reviews, Volume 4, October 2003 issue.


FISCHLER ON GMO CO-EXISTENCE

Commissioner Franz Fischler presented the European Union (EU) recommendation on the guidelines concerning the co-existence of GMOs with conventional and organic farming. According to Fischler, the question of safety and environmental risk assessment of GMOs is already well addressed under existing Community legislations on the authorization of GMOs. Thus, the guidelines on co-existence will not anymore address food safety or environmental concerns.

The Commissioner also reiterated his strong belief that the EU should be open to the possibility of using and developing biotechnology in European agriculture. He stated that by establishing the conditions for co-existence, farmers must be given the assurance that they may still use conventional and organic farming methods if they prefer to do so.

For the full story, http://europa.eu.int/rapid/start/cgi/guesten.ksh?p_action.gettxt=gt&
doc=MEMO/03/187|0|RAPID&lg=EN&display=


ECONOMICS OF AG-BIOTECH RESEARCH

The working paper of Carl E. Pray and Anwar Naseem entitled “The Economics of Agricultural Biotechnology Research,” examined the economic determinants and the impact of agricultural biotechnology research. The authors also assessed the capability of agricultural biotechnology and its potential to address the needs of the poor in developing countries.

Based on their analysis, Pray and Naseem states that the private sector in industrialized countries conducts research only if it expects that the financial benefits will outweigh the costs. Benefits are measured via the foreseen market size of the new technology, and the appropriate intellectual property rights.

On the other hand, the public sector, through research, is perceived as providing public goods that yield social benefits that are not captured by private firms. Public research, likewise, responds to factors such as markets for innovations and research costs similar to the private sector. However, apart from these considerations, public sector research must also fulfill political as well as financial goals.

Lastly, the authors observed that private research spending has so far caught up with public spending in the industrialized countries, but still lags far behind in developing countries.

The working paper is available at http://www.fao.org/es/ESA/wp/ESAWP03_07.pdf.


CHINESE CONSUMERS: LOW KNOWLEDGE OF GM FOODS

Chinese consumers (25%) have little knowledge of genetically modified (GM) food, and most of them believe that GM foods should be labeled. Media attention on the issue of GM foods have also increased and most of the articles written were negative in tone. These were the major findings of a case study done in Nanjing by Funing Zhong of the Nanjing Agricultural University, and colleagues.

Funing Zhong and colleagues also learned that Chinese consumers were not particular about how the production, marketing, and labeling of GM foods are regulated. What the consumers were mostly concerned about was that these food products are labeled.

The major findings of the case study are as follows:

  • Fifty percent (50%) of urban consumers have not heard of GM foods at all; and of those who are familiar with GM foods, only 25% said they knew something about GM foods.
  • Forty percent (40%) of Chinese urban consumers will buy GM foods based on basic information alone.
  • Twenty percent (20%) of consumers were convinced that GM foods are unsafe, while 30% to 50% still have not made up their minds about the acceptability of GM foods.
  • GM foods with nutritional enhancements and improved medical functions were more acceptable to consumers than pest resistant characteristics.
  • All consumers firmly believe that GM foods should be labeled, although labeling of such foods do not guarantee that consumers would be convinced about their safety.
  • Consumers who were younger, female, or had higher education were more reluctant to accept GM foods. Consumers who were older, male and less educated were more receptive to biotechnology.

A copy of the case study is available at http://www.agbioforum.org/v5n4/v5n4a02-zhong.htm.


NON-GM AND GM RAPE – BEES DON’T CARE

Honeybees, bumblebees, solitary bees and Diptera cannot discriminate between genetically modified (GM) rape and non-GM rape plants. Bees and other insects move freely from one rape plant to another regardless of their GM status, and thus are able to transfer pollen easily to one another. This is a gist of a finding of French researchers led by Jacquiline Pierre as they studied the foraging behavior of various bees.

In addition, similar insect numbers and behavior were found, and the equivalent plants showed similar nectar volume, nectar sugar concentration, and composition.

Pierre however cautions that the research does not generalize about GM plants having no impact on pollinator behavior. “In GM plants, a case by case approach is absolutely recommended,” she says.

The full paper entitled “Effects of Herbicide-tolerant Transgenic Oilseed Rape Genotypes on Honeybees and Other Pollinating Insects Under Field Conditions” is published in Entomologia Experimentalis et Applicata.

Email Jacqueline Pierre at pieere@rennes.inra.fr


ANNOUNCEMENT:

FUTURE OF FOOD & BIOTECH CONFERENCE

The Club of Amsterdam will hold a conference entitled “The Future of Food & Biotech,” on October 28, 2003, in Amsterdam, the Netherlands. Topics to be discussed are the impact of new technology on the food industry.

More information can be found at http://www.clubofamsterdam.com.

Do not hesitate to tell other colleagues/contacts about this mail list. If they wish to join, they should send an e-mail message to knowledge.center@isaaa.org leaving the subject blank and entering the one-line text message as follows: SUBSCRIBE Crop Biotech Network

To stop receiving this newsletter, please send an e-mail message to knowledge.center@isaaa.org and write, "unsubscribe newsletter" in the subject box.

Please visit CropBiotech Net web pages (http://www.isaaa.org/kc) to view previous issues of this newsletter and see other available resources for download.

While we are still developing this site, feel free to e-mail (knowledge.center@isaaa.org) us for your views and comments on any crop biotechnology product and related issues.
Home :: Global Status :: CBT Update :: Info Resource :: Events :: BICs :: Directory :: About Us :: Editorial Policy

Copyright © 2006. CropBiotech Net.